225 related articles for article (PubMed ID: 26611245)
21. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline.
Graf P; Juto JE
ORL J Otorhinolaryngol Relat Spec; 1994; 56(3):157-60. PubMed ID: 7515487
[TBL] [Abstract][Full Text] [Related]
22. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
Dorn M; Hofmann W; Knick E
HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532
[TBL] [Abstract][Full Text] [Related]
23. Effect of oxymetazoline nasal spray on intraocular pressure and retrobulbar hemodynamics.
Arikan OK; Akarsu C; Unal B; Ergin A; Koç C
J Otolaryngol; 2006 Feb; 35(1):30-5. PubMed ID: 16527014
[TBL] [Abstract][Full Text] [Related]
24. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways.
Svensson C; Pipkorn U; Alkner U; Baumgarten CR; Persson CG
Clin Exp Allergy; 1992 Mar; 22(3):411-6. PubMed ID: 1586878
[TBL] [Abstract][Full Text] [Related]
25. Effects of sustained-release oral phenylpropanolamine on the nasal mucosa of healthy subjects.
Graf P; Toll K; Palm J; Hallén H
Acta Otolaryngol; 1999; 119(7):837-42. PubMed ID: 10687944
[TBL] [Abstract][Full Text] [Related]
26. [The observation of the ciliotoxicity of nasal mucosa with nasal decongestant].
Teng Y; Zhang X; Xu G; Cai Q; Xu J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Sep; 19(18):824-6. PubMed ID: 16375111
[TBL] [Abstract][Full Text] [Related]
27. Vascular effects of topical oxymetazoline on human nasal mucosa.
Bende M; Löth S
J Laryngol Otol; 1986 Mar; 100(3):285-8. PubMed ID: 3950497
[TBL] [Abstract][Full Text] [Related]
28. Middle ear gas composition during nitrous oxide-oxygen ventilation.
Ostfeld E; Crispin M; Blonder J; Szeinberg A
Ann Otol Rhinol Laryngol; 1980; 89(2 Pt 1):165-7. PubMed ID: 6768334
[TBL] [Abstract][Full Text] [Related]
29. Middle ear pressure change during controlled breathing with gas mixtures containing nitrous oxide.
Doyle WJ; Banks JM
J Appl Physiol (1985); 2003 Jan; 94(1):199-204. PubMed ID: 12486021
[TBL] [Abstract][Full Text] [Related]
30. Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity.
Graf P; Hallén H; Juto JE
Acta Otolaryngol; 1995 Jan; 115(1):71-5. PubMed ID: 7762389
[TBL] [Abstract][Full Text] [Related]
31. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis.
Baroody FM; Brown D; Gavanescu L; DeTineo M; Naclerio RM
J Allergy Clin Immunol; 2011 Apr; 127(4):927-34. PubMed ID: 21377716
[TBL] [Abstract][Full Text] [Related]
32. The effects of topical agents of fluticasone propionate, oxymetazoline, and 3% and 0.9% sodium chloride solutions on mucociliary clearance in the therapy of acute bacterial rhinosinusitis in vivo.
Inanli S; Oztürk O; Korkmaz M; Tutkun A; Batman C
Laryngoscope; 2002 Feb; 112(2):320-5. PubMed ID: 11889391
[TBL] [Abstract][Full Text] [Related]
33. [The use of oxymetazoline in nasal endoscopic sinus surgery].
Zhen H; Gao Q; Cui Y; Hua X; Li H; Feng J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 May; 17(5):281-2. PubMed ID: 12916356
[TBL] [Abstract][Full Text] [Related]
34. An evaluation of nasal response following different treatment regimes of oxymetazoline with reference to rebound congestion.
Morris S; Eccles R; Martez SJ; Riker DK; Witek TJ
Am J Rhinol; 1997; 11(2):109-15. PubMed ID: 9129752
[TBL] [Abstract][Full Text] [Related]
35. Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis.
Graf P; Enerdal J; Hallén H
Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1128-32. PubMed ID: 10522506
[TBL] [Abstract][Full Text] [Related]
36. Effects of oxymetazoline on nasal flow and maximum aerobic exercise performance in patients with inferior turbinate hypertrophy.
Gómez-Hervás J; García-Valdecasas Bernal J; Fernández-Prada M; Palomeque-Vera JM; García-Ramos A; Fernández-Castanys BF
Laryngoscope; 2015 Jun; 125(6):1301-6. PubMed ID: 25546052
[TBL] [Abstract][Full Text] [Related]
37. Impact of allergic rhinitis and its treatment on the pharmacokinetics of nasally administered fentanyl.
Perelman M; Fisher AN; Smith A; Knight A
Int J Clin Pharmacol Ther; 2013 May; 51(5):349-56. PubMed ID: 23458227
[TBL] [Abstract][Full Text] [Related]
38. [Gas ventilation through middle ear mucosa].
Ohno F; Imakiire T; Nobori T; Ohyama M
Nihon Jibiinkoka Gakkai Kaiho; 1993 Nov; 96(11):1861-8. PubMed ID: 8283337
[TBL] [Abstract][Full Text] [Related]
39. Role of the mastoid in middle ear pressure regulation.
Alper CM; Kitsko DJ; Swarts JD; Martin B; Yuksel S; Cullen Doyle BM; Villardo RJ; Doyle WJ
Laryngoscope; 2011 Feb; 121(2):404-8. PubMed ID: 21271597
[TBL] [Abstract][Full Text] [Related]
40. Effects of oxymetazoline nasal spray on the nasal cycle assessed by long-term rhinoflowmetry.
Braun T; Rich M; Berghaus A; Kramer MF
Rhinology; 2012 Dec; 50(4):370-5. PubMed ID: 23181250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
